{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:14:58Z","timestamp":1784664898498,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T00:00:00Z","timestamp":1469923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00417-016-3436-5","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T18:05:38Z","timestamp":1469901938000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (CSCR)"],"prefix":"10.1007","volume":"255","author":[{"given":"Tina Rike","family":"Herold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Rist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried Georg","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Werner","family":"Ulbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,31]]},"reference":[{"issue":"11","key":"3436_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/bjo.68.11.815","volume":"68","author":"CM Gilbert","year":"1984","unstructured":"Gilbert CM, Owens SL, Smith PD, Fine SL (1984) Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol 68(11):815\u2013820. doi: 10.1136\/bjo.68.11.815","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3436_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002. Ophthalmology 115(1):169\u2013173. doi: 10.1016\/j.ophtha.2007.02.032","journal-title":"Ophthalmology"},{"issue":"1","key":"3436_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/bjophthalmol-2011-300183","volume":"96","author":"NC Steinle","year":"2012","unstructured":"Steinle NC, Gupta N, Yuan A, Singh RP (2012) Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy. Br J Ophthalmol 96(1):10\u201313. doi: 10.1136\/bjophthalmol-2011-300183","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"3436_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3928\/23258160-20130909-08","volume":"44","author":"L Roisman","year":"2013","unstructured":"Roisman L, Magalhaes FP, Lavinsky D, Moraes N, Hirai FE, Cardillo JA, Farah ME (2013) Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Ophthalmic Surg Lasers Imaging Retina 44(5):465\u2013470. doi: 10.3928\/23258160-20130909-08","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"12","key":"3436_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00347-012-2688-7","volume":"109","author":"I Beger","year":"2012","unstructured":"Beger I, Koss MJ, Koch F (2012) Treatment of central serous chorioretinopathy: MicroPulse photocoagulation versus bevacizumab. Ophthalmologe 109(12):1224\u20131232. doi: 10.1007\/s00347-012-2688-7","journal-title":"Ophthalmologe"},{"issue":"2","key":"3436_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/IAE.0b013e3182670fa3","volume":"33","author":"M Behnia","year":"2013","unstructured":"Behnia M, Khabazkhoob M, Aliakbari S, Abadi AE, Hashemi H, Pourvahidi P (2013) Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy. Retina 33(2):324\u2013328. doi: 10.1097\/IAE.0b013e3182670fa3","journal-title":"Retina"},{"issue":"5","key":"3436_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","volume":"121","author":"JI Lim","year":"2014","unstructured":"Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF (2014) Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 121(5):1073\u20131078. doi: 10.1016\/j.ophtha.2013.11.040","journal-title":"Ophthalmology"},{"issue":"10","key":"3436_CR8","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29(10):1469\u20131473. doi: 10.1097\/IAE.0b013e3181be0a83","journal-title":"Retina"},{"issue":"3","key":"3436_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","volume":"16","author":"RF Spaide","year":"1996","unstructured":"Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16(3):203\u2013213","journal-title":"Retina"},{"issue":"7","key":"3436_CR10","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1172\/jci61427","volume":"122","author":"M Zhao","year":"2012","unstructured":"Zhao M, Celerier I, Bousquet E, Jeanny JC, Jonet L, Savoldelli M, Offret O, Curan A, Farman N, Jaisser F, Behar-Cohen F (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672\u20132679. doi: 10.1172\/jci61427","journal-title":"J Clin Invest"},{"issue":"10","key":"3436_CR11","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","volume":"33","author":"E Bousquet","year":"2013","unstructured":"Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 33(10):2096\u20132102. doi: 10.1097\/IAE.0b013e318297a07a","journal-title":"Retina"},{"issue":"10","key":"3436_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/nejm199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341(10):709\u2013717. doi: 10.1056\/nejm199909023411001","journal-title":"N Engl J Med"},{"issue":"4","key":"3436_CR13","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","volume":"57","author":"JA Delyani","year":"2000","unstructured":"Delyani JA (2000) Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology. Kidney Int 57(4):1408\u20131411. doi: 10.1046\/j.1523-1755.2000.00983.x","journal-title":"Kidney Int"},{"issue":"12","key":"3436_CR14","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","volume":"252","author":"TR Herold","year":"2014","unstructured":"Herold TR, Prause K, Wolf A, Mayer WJ, Ulbig MW (2014) Spironolactone in the treatment of central serous chorioretinopathy - a case series. Graefes Arch Clin Exp Ophthalmol 252(12):1985\u20131991. doi: 10.1007\/s00417-014-2780-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3436_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00347-013-3001-0","volume":"111","author":"M Maier","year":"2014","unstructured":"Maier M, Stumpfe S, Feucht N, Strobl P, Rath V, Lohmann CP (2014) Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy. Ophthalmologe 111(2):173\u2013180. doi: 10.1007\/s00347-013-3001-0","journal-title":"Ophthalmologe"},{"issue":"12","key":"3436_CR16","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","volume":"35","author":"E Bousquet","year":"2015","unstructured":"Bousquet E, Beydoun T, Rothschild PR, Bergin C, Zhao M, Batista R, Brandely ML, Couraud B, Farman N, Gaudric A, Chast F, Behar-Cohen F (2015) Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study. Retina 35(12):2505\u20132515. doi: 10.1097\/IAE.0000000000000614","journal-title":"Retina"},{"issue":"2","key":"3436_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","volume":"41","author":"G Liew","year":"2013","unstructured":"Liew G, Quin G, Gillies M, Fraser-Bell S (2013) Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 41(2):201\u2013214. doi: 10.1111\/j.1442-9071.2012.02848.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"3436_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.5.2.2","volume":"5","author":"A Daruich","year":"2016","unstructured":"Daruich A, Matet A, Dirani A, Gallice M, Nicholson L, Sivaprasad S, Behar-Cohen F (2016) Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy. Transl Vision Sci Technol 5(2):2. doi: 10.1167\/tvst.5.2.2","journal-title":"Transl Vision Sci Technol"},{"issue":"1","key":"3436_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000444058","volume":"56","author":"KG Kapoor","year":"2016","unstructured":"Kapoor KG, Wagner AL (2016) Mineralocorticoid antagonists in the treatment of central serous chorioretinopathy: a comparative analysis. Ophthalmic Res 56(1):17-22. doi: 10.1159\/000444058","journal-title":"Ophthalmic Res"},{"key":"3436_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82\u2013118. doi: 10.1016\/j.preteyeres.2015.05.003","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"3436_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000360014","volume":"232","author":"R Liegl","year":"2014","unstructured":"Liegl R, Ulbig MW (2014) Central serous chorioretinopathy. Ophthalmol J Int 232(2):65\u201376. doi: 10.1159\/000360014","journal-title":"Ophthalmol J Int"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3436-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3436-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3436-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3436-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:34:49Z","timestamp":1498318489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3436-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,31]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3436"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3436-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,31]]}}}